We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$19B
AUM Growth
+$4.37B
Cap. Flow
+$3.05B
Cap. Flow %
16.07%
Top 10 Hldgs %
39.91%
Holding
1,362
New
110
Increased
730
Reduced
452
Closed
64

Sector Composition

Rank Sector Weight
1 Technology 35.28%
2 Financials 15.39%
3 Healthcare 5.04%
4 Energy 4.05%
5 Consumer Discretionary 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QNCX icon
1326
Quince Therapeutics
QNCX
$22.9M
-135
Closed -$2.47M
RCL icon
1327
Royal Caribbean
RCL
$85.1B
-12,595
Closed -$1.12M
RDFN
1328
DELISTED
Redfin
RDFN
-6,050
Closed -$303K
RDWR icon
1329
Radware
RDWR
$1.1B
-117,041
Closed -$3.95M
RLJ icon
1330
RLJ Lodging Trust
RLJ
$1.86B
-17,246
Closed -$256K
SITC icon
1331
SITE Centers
SITC
$225M
-13,981
Closed -$168K
SLE icon
1332
Super League Enterprise
SLE
$4.28M
-64
Closed -$1.92M
SOHU
1333
Sohu.com
SOHU
$362M
-198,785
Closed -$4.14M
SVC
1334
Service Properties Trust
SVC
$1.04B
-3,741
Closed -$210K
TBPH icon
1335
Theravance Biopharma
TBPH
$874M
-12,649
Closed -$94K
WU icon
1336
Western Union
WU
$1.98B
-73,890
Closed -$1.49M
XNET
1337
Xunlei
XNET
$340M
-667,260
Closed -$1.91M
XPRO icon
1338
Expro Ltd
XPRO
$1.79B
-6,743
Closed -$119K
EQC
1339
DELISTED
Equity Commonwealth
EQC
-7,878
Closed -$205K
AYX
1340
DELISTED
Alteryx Inc
AYX
-4,340
Closed -$317K
ORTX
1341
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-65,201
Closed -$1.5M
AMTI
1342
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
-46,664
Closed -$1.21M
SPPI
1343
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-690,370
Closed -$1.5M
HGEN
1344
DELISTED
HUMANIGEN, INC.
HGEN
-452,912
Closed -$2.69M
TCRR
1345
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-54,260
Closed -$462K
PRVB
1346
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-21,440
Closed -$137K
EPZM
1347
DELISTED
Epizyme, Inc
EPZM
-238,344
Closed -$1.22M
PLAN
1348
DELISTED
Anaplan, Inc.
PLAN
-3,559
Closed -$217K
DRNA
1349
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-143,589
Closed -$2.9M
COR
1350
DELISTED
Coresite Realty Corporation
COR
-2,937
Closed -$407K

Similar funds

Rafferty Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Rafferty Asset Management held 1,362 positions worth $19B, up 30% from $14.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rafferty Asset Management deployed $3.05B of net new capital in Q4 2021, opening 110 new positions and adding to 730 existing holdings. Its largest new stake was Aflac: 345,009 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $81.8M trimmed.

  • Rafferty Asset Management's largest Q4 2021 buy was Aflac: 345,009 shares worth $20.1M.
  • Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $492M increase.
  • Rafferty Asset Management's biggest Q4 2021 reduction was VanEck Gold Miners ETF, cutting an estimated $81.8M.
  • Rafferty Asset Management fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $8.07M.
  • Rafferty Asset Management's ten largest holdings make up 40% of its $19B portfolio in Q4 2021.
  • Rafferty Asset Management opened 110 new positions and closed 64 in Q4 2021.
  • Rafferty Asset Management's portfolio value rose 30% quarter-over-quarter to $19B.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.